Waterloo Regional Health Network (WRHN)

The trials here

What the 4 trials at this site are about, from their registry records.

Conditions

• Liver and biliary tract cancer1 trial
• Melanoma1 trial
• Multiple myeloma1 trial
• Prostate cancer1 trial

Phase

• Phase 33 trials
• Phase 21 trial

Status

• Recruiting4 trials

Lead sponsor

• Canadian Cancer Trials Group4 trials

Running trials

• Recruiting

  STRIDE (Durvalumab + Tremelimumab) With Lenvatinib vs STRIDE Alone in Unresectable Hepatocellular Carcinoma

  NCT06880523· Phase 2· Canadian Cancer Trials Group· Source

  Contact: Anupam Batra

• Recruiting

  Platinum and Taxane Chemo in Met Castration Resistant Prostate Cancer Patients With Alterations in DNA Damage Response Genes

  NCT06439225· Phase 3· Canadian Cancer Trials Group· Source

  Contact: Anupam Batra

• Recruiting

  Fixed Duration vs Continuous Anti-CD38 Antibody Therapy Among Transplant Ineligible Older Adults With Newly-Diagnosed Multiple Myeloma

  NCT06182774· Phase 3· Canadian Cancer Trials Group· Source

  Contact: Armela Dicu

• Recruiting

  Duration of Anti-PD-1 Therapy in Metastatic Melanoma

  NCT02821013· Phase 3· Canadian Cancer Trials Group· Source

  Contact: Gregory J. Knight

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Liver and biliary tract cancer1 recruiting
• Melanoma1 recruiting
• Multiple myeloma1 recruiting
• Prostate cancer1 recruiting